ID
33137
Descripción
ADVANCED PROSTATE CANCER DATA COLLECTION Version 2.3.1 Revised: April 10th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Conditions: All patients with advanced prostate cancer, either having metastatic disease or biochemical recurrence progressing after salvage treatment or ineligible for salvage treatment. Patients with biochemical recurrence treated with salvage therapy are referred to the localized prostate cancer set. Treatment Approaches: Hormonal Therapy | Chemotherapy | Immunotherapy | Radiopharmaceuticals | Radiation | Interventions for Complications of Local Progression This form contains patient-reported outcome variables. To be assessed 6 months and 1 year post (initial) treatment and annually for life from then on. Questionnaires used in this form: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC‐CP rather than the EPIC‐26, we recommend using the same variable IDs as the corresponding EPIC‐26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed (according to ICHOM). Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): For use of the EORTC QLQ-C30 a license is needed, therefore the questions will not be part of this version of the standard set. (eortc.be) The following paper has been published about development of this standard set: Morgans AK, van Bommel ACM, Stowell C, Abrahm JL, Basch E, Bekelman JE, et al. Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. Eur Urol. 2015 Nov;68(5):891–8. For the standard set ICHOM has been supported by the Movember Foundation.
Link
Palabras clave
Versiones (2)
- 29/11/18 29/11/18 - Sarah Riepenhausen
- 30/4/20 30/4/20 - Sarah Riepenhausen
Titular de derechos de autor
ICHOM
Subido en
29 de noviembre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
ICHOM Advanced Prostate Cancer
Follow-Up Patient-reported Form
- StudyEvent: ODM
Descripción
Degree of health
Alias
- UMLS CUI-1
- C0018759
Descripción
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0002771
- UMLS CUI [1,2]
- C1298908
Descripción
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0002771
- UMLS CUI [1,2]
- C2709201
- UMLS CUI [2,1]
- C0002771
- UMLS CUI [2,2]
- C0013231
Descripción
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0002771
- UMLS CUI [1,2]
- C0304227
- UMLS CUI [2]
- C0027409
- UMLS CUI [3]
- C0002772
Descripción
As a license is needed for use of this questionnaire, the 30 actual questions are not included in this version of the standard set. ICHOM IDs are EORTCQLQC30_Q01 up to EORTCQLQC30_Q30. INCLUSION CRITERIA: All patients TIMING: Baseline, 30 days + annually up to 5 years after index event REPORTING SOURCE: Patient-reported TYPE: Numerical (each question is single answer in original set)
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C4055104
- UMLS CUI [1,2]
- C2964552
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289637
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289645
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289630
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289641
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289629
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289644
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289625
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289626
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289631
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289627
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289636
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289634
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4287870
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289649
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289633
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289647
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289646
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289628
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289639
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289648
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289632
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289638
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289643
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289640
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289635
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4289642
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C3899191
Descripción
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C3827672
Descripción
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0663448
Descripción
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2366566
Descripción
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C3828613
Descripción
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C3827672
Descripción
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1115771
Similar models
Follow-Up Patient-reported Form
- StudyEvent: ODM
C1442488 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,2])
C2709201 (UMLS CUI [1,2])
C0002771 (UMLS CUI [2,1])
C0013231 (UMLS CUI [2,2])
C0304227 (UMLS CUI [1,2])
C0027409 (UMLS CUI [2])
C0002772 (UMLS CUI [3])
C2964552 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C0558293 (UMLS CUI-2)
(Comment:en)
(Comment:en)
C2003901 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0549184 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0549184 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)